For citations:
Gusarevich A.A., Zavadski P.C., Kuroyedov A.V., Gazizova I.R., Zvereva O.G., Karimov U.R., Filippov P.G., Diordiichuk S.V., Dorofeev D.A., Kosmynina S.V., Avdeev R.V., Gorodnichii V.V., Zakhidov A.B., Zubasheva S.A., Bakunina N.A., Baryshnikova D.A., Basinskiy A.S., Gabdrakhmanov L.M., Gaponko O.V., Gar’kavenko V.V., Getmanova A.M., Zhavoronkov S.A., Kondrakova I.V., Lanin S.N., Molchanova E.V., Myakonkaya O.S., Rabianok N.A., Razhko Yu.I., Chernyakova T.V., Shakhalova A.P., Iuldashev A.M. The correct choice of monotherapy with prostaglandin analogues/ prostamides at the start of treatment for newly diagnosed glaucoma (results of a multicenter study). National Journal glaucoma. 2020;19(3):43-57. (In Russ.) https://doi.org/10.25700/NJG.2020.03.05